车站3
结直肠癌
癌症研究
STAT蛋白
串扰
免疫系统
肿瘤微环境
医学
靶向治疗
肿瘤进展
大肠癌小鼠模型的建立
肿瘤发生
免疫疗法
癌症
生物
免疫学
信号转导
癌变
内科学
细胞生物学
物理
光学
作者
Lili Huang,Yan Zhao,Mengying Shan,Sitong Wang,Jianhua Chen,Zhuqing Liu,Qing Xu
标识
DOI:10.1080/15384047.2023.2226418
摘要
A comprehensive analysis of the molecular mechanism underlying colorectal tumor evaluated the development of colorectal cancer (CRC) and proposed targeting small molecular inhibitors. Nonetheless, the adoptive resistance of these therapies remains a challenge with respect to achieving an effective clinical response. Thus, identifying the molecular mechanisms guiding CRC growth is essential. The results of The Cancer Genome Atlas (TCGA) dataset analysis demonstrated a critical role of signal transducer and activator of transcription 3 (STAT3) pathway in tumor immune suppression via modulation of the recruitment of Treg cells and M2 type tumor-associated macrophages. The in vivo experiments elucidate that targeting STAT3 pathways markedly reduce the proportions of TAMs and Tregs by inhibiting tumor progression. These findings revealed crosstalk between Treg cells and M2 macrophages, proving a potential therapeutic strategy for CRC therapy. Combinatorial treatment with STAT3 inhibitor and programmed death 1 (PD-1) antibody therapy effectively prevents CRC tumor growth in a mouse model with high anti-tumor immunity. In summary, targeting STAT3 disrupts the interaction between Treg cells and M2 macrophages and improves the anti-tumor response in CRC, thereby offering a promising strategy to treat patients with CRC.
科研通智能强力驱动
Strongly Powered by AbleSci AI